Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy
Bharat Biotech has released the final phase 3 efficacy data. The company claims it's made in India vaccine, Covaxin, has shown overall efficacy of 77.8%. The data, however, is yet to be peer-reviewed.
![[Sponsored] Make Study Time Smarter with Samsung Galaxy Tab S10 FE+](https://c.ndtvimg.com/2025-05/4pci6id4_image_160x120_23_May_25.jpg?downsize=355∶533 "[Sponsored] Make Study Time Smarter with Samsung Galaxy Tab S10 FE+")
![[Sponsored] Creativity, Unlocked With Samsung Galaxy Tab S10 FE+](https://c.ndtvimg.com/2025-05/njto1av4_image_160x120_23_May_25.jpg?downsize=355∶533 "[Sponsored] Creativity, Unlocked With Samsung Galaxy Tab S10 FE+")
